Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H14N3O8P |
Molecular Weight | 323.1965 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]2O
InChI
InChIKey=IERHLVCPSMICTF-XVFCMESISA-N
InChI=1S/C9H14N3O8P/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H2,10,11,15)(H2,16,17,18)/t4-,6-,7-,8-/m1/s1
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischaemia. | 2001 |
|
Phosphopantothenoylcysteine synthetase from Escherichia coli. Identification and characterization of the last unidentified coenzyme A biosynthetic enzyme in bacteria. | 2001 Apr 27 |
|
A molecular dynamics study based post facto free energy analysis of the binding of bovine angiogenin with UMP and CMP ligands. | 2001 Feb-Apr |
|
Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells. | 2001 Mar |
|
Characterization of alpha(2-->6)-sialyltransferase reaction intermediates: use of alternative substrates to unmask kinetic isotope effects. | 2002 |
|
Production of cytidine 5'-monophosphate N-acetylneuraminic acid using recombinant Escherichia coli as a biocatalyst. | 2002 Dec 5 |
|
Structure and mechanism of CTP:phosphocholine cytidylyltransferase (LicC) from Streptococcus pneumoniae. | 2002 Feb 8 |
|
Reversible substrate-induced domain motions in ribonuclease A. | 2002 Jan 1 |
|
Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2. | 2002 Jul |
|
Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase. | 2002 Jul 18 |
|
Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates. | 2002 Mar 15 |
|
Nuclear localization signal of murine CMP-Neu5Ac synthetase includes residues required for both nuclear targeting and enzymatic activity. | 2002 May 31 |
|
A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog. | 2003 Jan-Feb |
|
Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. | 2003 May 9 |
|
cis-acting elements at opposite ends of the Citrus tristeza virus genome differ in initiation and termination of subgenomic RNAs. | 2004 Apr 25 |
|
Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia. | 2004 Dec |
|
Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition. | 2004 Sep |
|
A comprehensive update of the sequence and structure classification of kinases. | 2005 Mar 16 |
|
Structure of Staphylococcus aureus cytidine monophosphate kinase in complex with cytidine 5'-monophosphate. | 2006 Aug 1 |
|
Cytidine 5'-monophosphate (CMP)-induced structural changes in a multifunctional sialyltransferase from Pasteurella multocida. | 2006 Feb 21 |
|
Functional expression of the CMP-sialic acid transporter in Escherichia coli and its identification as a simple mobile carrier. | 2006 Jan |
|
Metabolic engineering of microbes for oligosaccharide and polysaccharide synthesis. | 2006 Jul 21 |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CYTIDINE MONOPHOSPHATE
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
DB03403
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
1162126
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
SUB93372
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
100000141558
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
F469818O25
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
DTXSID50889322
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
200-556-6
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
63-37-6
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
50308
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
6131
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY | |||
|
17361
Created by
admin on Fri Dec 15 15:00:17 GMT 2023 , Edited by admin on Fri Dec 15 15:00:17 GMT 2023
|
PRIMARY |
SALT/SOLVATE (PARENT)
SUBSTANCE RECORD